Ikarian Capital’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-132,014
| Closed | -$378K | – | 77 |
|
|
2022
Q2 | $378K | Sell |
132,014
-2
| -0% | -$6 | 0.07% | 69 |
|
|
2022
Q1 | $1.07M | Buy |
132,016
+9,709
| +8% | +$78.5K | 0.14% | 66 |
|
|
2021
Q4 | $978K | Hold |
122,307
| – | – | 0.15% | 72 |
|
|
2021
Q3 | $1.46M | Sell |
122,307
-4,508
| -4% | -$53.7K | 0.1% | 82 |
|
|
2021
Q2 | $1.97M | Hold |
126,815
| – | – | 0.16% | 84 |
|
|
2021
Q1 | $3.04M | Hold |
126,815
| – | – | 0.1% | 78 |
|
|
2020
Q4 | $3.74M | Sell |
126,815
-27,176
| -18% | -$802K | 0.16% | 48 |
|
|
2020
Q3 | $2.36M | Buy |
153,991
+50,000
| +48% | +$765K | 0.17% | 54 |
|
|
2020
Q2 | $2.6M | Hold |
103,991
| – | – | 0.21% | 40 |
|
|
2020
Q1 | $2.12M | Buy |
+103,991
| New | +$2.12M | 0.16% | 36 |
|